000 | 01136 a2200337 4500 | ||
---|---|---|---|
005 | 20250516205519.0 | ||
264 | 0 | _c20150113 | |
008 | 201501s 0 0 eng d | ||
022 | _a1469-3178 | ||
024 | 7 |
_a10.1002/embr.201438641 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKampourakis, Kostas | |
245 | 0 | 0 |
_aKey challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. _h[electronic resource] |
260 |
_bEMBO reports _cMay 2014 |
||
300 |
_a472-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aDrug Resistance _xgenetics |
650 | 0 | 4 | _aGenetic Variation |
650 | 0 | 4 | _aGenomics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPrecision Medicine |
700 | 1 | _aVayena, Effy | |
700 | 1 | _aMitropoulou, Christina | |
700 | 1 | _avan Schaik, Ron H | |
700 | 1 | _aCooper, David N | |
700 | 1 | _aBorg, Joseph | |
700 | 1 | _aPatrinos, George P | |
773 | 0 |
_tEMBO reports _gvol. 15 _gno. 5 _gp. 472-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/embr.201438641 _zAvailable from publisher's website |
999 |
_c23728833 _d23728833 |